BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report. Jiang L, Yang P, Liu Y, Li J, et al. J Cancer Res Clin Oncol 2024;150:162.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang L, Yang P, Liu Y, Li J, et al. BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report. J Cancer Res Clin Oncol 2024;150:162.
PMID: 38538919